Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial
Open Access
- 1 May 2019
- journal article
- research article
- Published by Elsevier in eClinicalMedicine
- Vol. 11, 34-43
Abstract
No abstract availableKeywords
Funding Information
- Alzheimer's Society (AS-PG-14-033)
- European Union (666881)
- Stroke Association Princess Margaret Research Development Fellowship scheme
- Stroke Association Garfield Weston Foundation Senior Clinical Lectureship
- NHS Research Scotland
- China Scholarship Council
- University of Edinburgh
- NHS Lothian Research and Development Office
- Row Fogo Charitable Trust
- Scottish Funding Council
- Fondation Leducq (16 CVD 05)
- Edinburgh and Lothians Health Foundation
- National Institute for Health Research
- BHF
- NIHR Clinical Research network (CRN) East Midlands
This publication has 30 references indexed in Scilit:
- Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationThe Lancet Neurology, 2013
- Mechanisms of sporadic cerebral small vessel disease: insights from neuroimagingThe Lancet Neurology, 2013
- Clinical and Pathological Improvement in Stroke-Prone Spontaneous Hypertensive Rats Related to the Pleiotropic Effect of CilostazolStroke, 2012
- A Systematic Review of Dynamic Cerebral and Peripheral Endothelial Function in Lacunar Stroke Versus ControlsStroke, 2010
- Differing Risk Factor Profiles of Ischemic Stroke SubtypesStroke, 2010
- The vascular and biochemical effects of cilostazol in patients with peripheral arterial diseaseJournal of Vascular Surgery, 2009
- Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirinPlatelets, 2009
- Cilostazol alleviates cerebral small-vessel pathology and white-matter lesions in stroke-prone spontaneously hypertensive ratsBrain Research, 2008
- Effect on platelet function of cilostazol, clopidogrel, and aspirin, each alone or in combinationAtherosclerosis Supplements, 2005
- Cilostazol: Potential mechanism of action for antithrombotic effects accompanied by a low rate of bleedingAtherosclerosis Supplements, 2005